How do you talk to patients about psychedelic clinical trials for the treatment of major depressive disorder or PTSD?

When do you consider referring a patient to a clinical trial? How have patients responded to being offered trial participation? What has your experience been with patient selection and eligibility?

Answer from: at Community Practice

These discussions usually come up with patients who have not been satisfied with prior pharmacologic treatments for depression or PTSD. I see my role as educating patients so that they can make the choice that is best for them. I will talk to them about the potential risks and benefits of psychedeli...

Comments

at Private Practice
Patients and families often come with exuberance a...

at Array Behavioral Care
How would you describe the risks and benefits? Do ...

Please select the option that best describes you:

How do you talk to patients about psychedelic clinical trials for the treatment of major depressive disorder or PTSD?

Related Questions